Abstract
Aspirin (Asp) therapy reduces the risk of arterial thrombotic events. However, aspirin-related adverse effects, particularly cerebral hemorrhage with its high mortality and disability rates, remain a significant concern. Interestingly, long-term antiplatelet therapy does not appear to exacerbate bleeding severity in patients with hemorrhagic cerebrovascular disease, suggesting potential compensatory mechanisms inducing platelet activation post-hemorrhage. Brain-derived microvesicles (BDMVs) have been implicated in platelet activation, although the underlying molecular mechanisms are unclear. This study employed flow cytometry (FCM), ELISA, and hopping probe ion conductance microscopy (HPICM) to demonstrate that BDMVs significantly activate and induce morphological changes in aspirin-treated platelets. We discovered the presence of cyclooxygenase-1 (COX-1) on BDMVs. Then, the phosphorylated proteomics was used to analyze the effect of BDMVs on aspirin-treated platelet quantitatively and validate the involvement of several signaling molecules. Biological validation showed that BDMVs increased phospholipase C (PLC), protein kinase C (PKC) and Akt phosphorylation. We also used PLC inhibitor U73122 to treat BDMV-intervened platelet and found reduced phosphorylation of the downstream signaling molecule PKC. These findings suggest that COX-1 within BDMVs may partially counteract the inhibitory effect of aspirin on platelets. Furthermore, BDMVs, combined with arachidonic acid (AA), activate aspirin-treated platelets and suggest the involvement of the PLC/PKC pathway. This study provides a theoretical basis for the early treatment of patients with clinical aspirin-related cerebral hemorrhage.
Data availability
All data generated or analyzed during this study are included in this published article.
References
Assadian, A. et al. Aspirin resistance among long-term aspirin users after carotid endarterectomy and controls: flow cytometric measurement of aspirin-induced platelet Inhibition. J. Vasc. Surg. 45, 1142–1147. https://doi.org/10.1016/j.jvs.2007.01.064 (2007). discussion 1147.
Roffi, M. et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur. Heart J. 37, 267–315. https://doi.org/10.1093/eurheartj/ehv320 (2016).
Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet Neurol. 20, 795–820. https://doi.org/10.1016/s1474-4422(21)00252-0 (2021).
Gross, B. A., Jankowitz, B. T. & Friedlander, R. M. Cerebral intraparenchymal hemorrhage: A review. Jama 321, 1295–1303. https://doi.org/10.1001/jama.2019.2413 (2019).
Hostettler, I. C., Seiffge, D. J. & Werring, D. J. Intracerebral hemorrhage: an update on diagnosis and treatment. Expert Rev. Neurother. 19, 679–694. https://doi.org/10.1080/14737175.2019.1623671 (2019).
Ivascu, F. A. et al. Predictors of mortality in trauma patients with intracranial hemorrhage on preinjury aspirin or clopidogrel. J. Trauma. 65, 785–788. https://doi.org/10.1097/TA.0b013e3181848caa (2008).
Nishijima, D. K., Zehtabchi, S., Berrong, J. & Legome, E. Utility of platelet transfusion in adult patients with traumatic intracranial hemorrhage and preinjury antiplatelet use: a systematic review. J. Trauma. Acute Care Surg. 72, 1658–1663. https://doi.org/10.1097/TA.0b013e318256dfc5 (2012).
Sansing, L. H. et al. Prior antiplatelet use does not affect hemorrhage growth or outcome after ICH. Neurology 72, 1397–1402. https://doi.org/10.1212/01.wnl.0000342709.31341.88 (2009).
Zhou, L. et al. Microparticles: new light shed on the Understanding of venous thromboembolism. Acta Pharmacol. Sin. 35, 1103–1110. https://doi.org/10.1038/aps.2014.73 (2014).
Schiro, A. et al. Endothelial microparticles as conveyors of information in atherosclerotic disease. Atherosclerosis 234, 295–302. https://doi.org/10.1016/j.atherosclerosis.2014.03.019 (2014).
Geddings, J. E. & Mackman, N. Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients. Blood 122, 1873–1880. https://doi.org/10.1182/blood-2013-04-460139 (2013).
Kaptan, K., Beyan, C., Ifran, A. & Pekel, A. Platelet-derived microparticle levels in women with recurrent spontaneous abortion. Int. J. Gynaecol. Obstet. 102, 271–274. https://doi.org/10.1016/j.ijgo.2008.04.007 (2008).
Park, M. S. et al. Quantification of hypercoagulable state after blunt trauma: microparticle and thrombin generation are increased relative to injury severity, while standard markers are not. Surgery 151, 831–836. https://doi.org/10.1016/j.surg.2011.12.022 (2012).
Booth, A. M. et al. Exosomes and HIV gag bud from endosome-like domains of the T cell plasma membrane. J. Cell Biol. 172, 923–935. https://doi.org/10.1083/jcb.200508014 (2006).
Laso-García, F. et al. Protein content of blood-derived extracellular vesicles: an approach to the pathophysiology of cerebral hemorrhage. Front. Cell. Neurosci. 16, 1058546. https://doi.org/10.3389/fncel.2022.1058546 (2022).
van Niel, G., D’Angelo, G. & Raposo, G. Shedding light on the cell biology of extracellular vesicles. Nat. Rev. Mol. Cell Biol. 19, 213–228. https://doi.org/10.1038/nrm.2017.125 (2018).
Urabe, F. et al. Extracellular vesicles as biomarkers and therapeutic targets for cancer. Am. J. Physiol. Cell Physiol. 318, C29–c39. https://doi.org/10.1152/ajpcell.00280.2019 (2020).
Ratajczak, M. Z. & Ratajczak, J. Extracellular microvesicles/exosomes: discovery, disbelief, acceptance, and the future? Leukemia 34, 3126–3135. https://doi.org/10.1038/s41375-020-01041-z (2020).
Alkhamis, T. M., Beissinger, R. L. & Chediak, J. R. Artificial surface effect on red blood cells and platelets in laminar shear flow. Blood 75, 1568–1575 (1990).
Schwager, S. C. & Reinhart-King, C. A. Mechanobiology of microvesicle release, uptake, and microvesicle-mediated activation. Curr. Top. Membr. 86, 255–278. https://doi.org/10.1016/bs.ctm.2020.08.004 (2020).
Raposo, G. & Stoorvogel, W. Extracellular vesicles: exosomes, microvesicles, and friends. J. Cell Biol. 200, 373–383. https://doi.org/10.1083/jcb.201211138 (2013).
Chen, Y. T., Yuan, H. X., Ou, Z. J. & Ou, J. S. Microparticles (Exosomes) and atherosclerosis. Curr. Atheroscler. Rep. 22, 23. https://doi.org/10.1007/s11883-020-00841-z (2020).
Porro, C., Trotta, T. & Panaro, M. A. Microvesicles in the brain: Biomarker, messenger or mediator? J. Neuroimmunol. 288, 70–78. https://doi.org/10.1016/j.jneuroim.2015.09.006 (2015).
Tian, Y. et al. Brain-derived microparticles induce systemic coagulation in a murine model of traumatic brain injury. Blood 125, 2151–2159. https://doi.org/10.1182/blood-2014-09-598805 (2015).
Zhao, Z. et al. Extracellular mitochondria released from traumatized brains induced platelet procoagulant activity. Haematologica 105, 209–217. https://doi.org/10.3324/haematol.2018.214932 (2020).
Leitner, A. Enrichment strategies in phosphoproteomics. Methods Mol. Biol. (Clifton N J). 1355, 105–121. https://doi.org/10.1007/978-1-4939-3049-4_7 (2016).
Zahedi, R. P., Begonja, A. J., Gambaryan, S. & Sickmann, A. Phosphoproteomics of human platelets: A quest for novel activation pathways. Biochim. Biophys. Acta. 1764, 1963–1976. https://doi.org/10.1016/j.bbapap.2006.08.017 (2006).
Zhao, R. T. et al. Circular ribonucleic acid expression alteration in exosomes from the brain extracellular space after traumatic brain injury in mice. J. Neurotrauma. 35, 2056–2066. https://doi.org/10.1089/neu.2017.5502 (2018).
Michelson, A. D. Flow cytometry: a clinical test of platelet function. Blood 87, 4925–4936 (1996).
McEver, R. P. Selectin-carbohydrate interactions during inflammation and metastasis. Glycoconj. J. 14, 585–591. https://doi.org/10.1023/a:1018584425879 (1997).
Serebruany, V. L., McKenzie, M. E., Levin, D. J. & Gurbel, P. A. Monitoring platelet Inhibition during chronic oral platelet glycoprotein IIb/IIIa blockade: are we missing something? Thromb. Haemost. 83, 356–357 (2000).
Liu, X. et al. Use of non-contact hopping probe ion conductance microscopy to investigate dynamic morphology of live platelets. Platelets 26, 480–485. https://doi.org/10.3109/09537104.2014.940888 (2015).
Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367–1372. https://doi.org/10.1038/nbt.1511 (2008).
Cox, J. et al. Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol. Cell. Proteomics: MCP. 13, 2513–2526. https://doi.org/10.1074/mcp.M113.031591 (2014).
Ashburner, M. et al. Gene ontology: tool for the unification of biology. The gene ontology consortium. Nat. Genet. 25, 25–29. https://doi.org/10.1038/75556 (2000).
Cheng, A., Grant, C. E., Noble, W. S. & Bailey, T. L. MoMo: discovery of statistically significant post-translational modification motifs. Bioinf. (Oxford England). 35, 2774–2782. https://doi.org/10.1093/bioinformatics/bty1058 (2019).
Edbauer, D. et al. Identification and characterization of neuronal mitogen-activated protein kinase substrates using a specific phosphomotif antibody. Mol. Cell. Proteomics: MCP. 8, 681–695. https://doi.org/10.1074/mcp.M800233-MCP200 (2009).
Seyfert, U. T., Haubelt, H., Vogt, A. & Hellstern, P. Variables influencing Multiplate(TM) whole blood impedance platelet aggregometry and turbidimetric platelet aggregation in healthy individuals. Platelets 18, 199–206. https://doi.org/10.1080/09537100600944277 (2007).
Melki, I., Tessandier, N., Zufferey, A. & Boilard, E. Platelet microvesicles in health and disease. Platelets 28, 214–221. https://doi.org/10.1080/09537104.2016.1265924 (2017).
Duchez, A. C. et al. Platelet microparticles are internalized in neutrophils via the concerted activity of 12-lipoxygenase and secreted phospholipase A2-IIA. Proc. Natl. Acad. Sci. U.S.A. 112, E3564–3573. https://doi.org/10.1073/pnas.1507905112 (2015).
Vanhoutte, P. M. COX-1 and vascular disease. Clin. Pharmacol. Ther. 86, 212–215. https://doi.org/10.1038/clpt.2009.108 (2009).
Vane, J. R., Bakhle, Y. S. & Botting, R. M. Cyclooxygenases 1 and 2. Annu. Rev. Pharmacol. Toxicol. 38, 97–120. https://doi.org/10.1146/annurev.pharmtox.38.1.97 (1998).
Dec, K. et al. Long-term exposure to fluoride as a factor promoting changes in the expression and activity of cyclooxygenases (COX1 and COX2) in various rat brain structures. Neurotoxicology 74, 81–90. https://doi.org/10.1016/j.neuro.2019.06.001 (2019).
Hankey, G. J. & Eikelboom, J. W. Aspirin resistance. Lancet (London England). 367, 606–617. https://doi.org/10.1016/s0140-6736(06)68040-9 (2006).
Macchi, L., Sorel, N. & Christiaens, L. Aspirin resistance: definitions, mechanisms, prevalence, and clinical significance. Curr. Pharm. Des. 12, 251–258. https://doi.org/10.2174/138161206775193064 (2006).
Khismatullin, R. R. et al. Pathology of lung-specific thrombosis and inflammation in COVID-19. J. Thromb. Haemostasis: JTH. 19, 3062–3072. https://doi.org/10.1111/jth.15532 (2021).
Denorme, F. & Campbell, R. A. Procoagulant platelets: novel players in thromboinflammation. Am. J. Physiol. Cell Physiol. 323, C951–c958. https://doi.org/10.1152/ajpcell.00252.2022 (2022).
Kulkarni, P. P. & McCrae, K. R. Comprehensive analysis of procoagulant platelets exhibiting features of Necrosis, apoptosis and platelet activation. J. Vis. Exp. JoVE. https://doi.org/10.3791/68116 (2025).
Veuthey, L., Aliotta, A., Bertaggia Calderara, D., Pereira Portela, C. & Alberio, L. Mechanisms underlying dichotomous procoagulant COAT platelet Generation-A conceptual review summarizing current knowledge. Int. J. Mol. Sci. 23 https://doi.org/10.3390/ijms23052536 (2022).
Prus, G., Hoegl, A., Weinert, B. T. & Choudhary, C. Analysis and interpretation of protein Post-Translational modification site stoichiometry. Trends Biochem. Sci. 44, 943–960. https://doi.org/10.1016/j.tibs.2019.06.003 (2019).
Cox, J. et al. Andromeda: a peptide search engine integrated into the MaxQuant environment. J. Proteome Res. 10, 1794–1805. https://doi.org/10.1021/pr101065j (2011).
Lee, E. E., Winston-Gray, C., Barlow, J. W., Rissman, R. A. & Jeste, D. V. Plasma levels of neuron- and astrocyte-derived exosomal amyloid Beta1-42, amyloid Beta1-40, and phosphorylated Tau levels in schizophrenia patients and Non-psychiatric comparison subjects: relationships with cognitive functioning and psychopathology. Front. Psychiatry. 11, 532624. https://doi.org/10.3389/fpsyt.2020.532624 (2020).
Küry, S. et al. De novo mutations in protein kinase genes CAMK2A and CAMK2B cause intellectual disability. Am. J. Hum. Genet. 101, 768–788. https://doi.org/10.1016/j.ajhg.2017.10.003 (2017).
Bill, C. A. & Vines, C. M. Phospholipase C. Adv. Exp. Med. Biol. 1131, 215–242. Doi:https://doi.org/10.1007/978-3-030-12457-1_9 (2020).
Stabel, S. & Parker, P. J. Protein kinase C. Pharmacol. Ther. 51, 71–95. https://doi.org/10.1016/0163-7258(91)90042-k (1991).
Moore, D. T., Berger, B. W. & DeGrado, W. F. Protein-protein interactions in the membrane: sequence, structural, and biological motifs. Structure (London, England). 16, 991–1001. https://doi.org/10.1016/j.str.2008.05.007 (2008).
Ardito, F., Giuliani, M., Perrone, D., Troiano, G. & Lo Muzio, L. The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy (Review). Int. J. Mol. Med. 40, 271–280. https://doi.org/10.3892/ijmm.2017.3036 (2017).
Rubenstein, D. A. & Yin, W. Platelet-activation mechanisms and vascular remodeling. Compr. Physiol. 8, 1117–1156. https://doi.org/10.1002/cphy.c170049 (2018).
Li, Z., Delaney, M. K., O’Brien, K. A. & Du, X. Signaling during platelet adhesion and activation. Arterioscler. Thromb. Vasc. Biol. 30, 2341–2349. https://doi.org/10.1161/atvbaha.110.207522 (2010).
Funding
This study was funded by major project of the Tianjin Natural Science Foundation (Tianjin Municipal Science and Technology Commission) (No. 21ZXJBSY00050) and the National Natural Science Foundation of China (No. 81971173 and 82371386).
Author information
Authors and Affiliations
Contributions
Y.H. performed the experiments, analyzed the data and wrote the paper; J.Z., Y.W., and X.L. participated in the execution of the experiment; R.Z. and Y.G. contributed to analysis and manuscript preparation; H.Y. and Y.T. contributed to the conception of the study. All authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
He, Yf., Zhang, Jc., Wang, Yz. et al. Brain-derived microvesicles induce activation of aspirin-treated platelets via the PLC/PKC pathway. Sci Rep (2026). https://doi.org/10.1038/s41598-026-39509-0
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-026-39509-0